Tab Repaglindine 0 Point 5 Mg,Tab Baclofen 10 Mg,Tab Risperidone 2 Mg,Tab Rivaroxaban 10 Mg,Tab Riv

By: MINISTRY OF DEFENCE - DEPARTMENT OF MILITARY AFFAIRS๐Ÿ“ IndiaOpen

Key Information

ReferenceGB-GEM/2026/B/7967055
DeadlineSep 7, 2026 12:00 AM
Competition TypeNCB
Funding SourceSelf-Funded
CountryIndia
AddressCountry: India
PublishedAug 27, 2026

Description

Tab Repaglindine 0 Point 5 Mg,Tab Baclofen 10 Mg,Tab Risperidone 2 Mg,Tab Rivaroxaban 10 Mg,Tab Riv Quantity: 50974 Start Date: 27-08-2026 1:43 PM End Date: 07-09-2026 2:00 PM Ministry of Defence...

Full details are available after unlocking this tender.